Belly Button (Credit: Canva)
The belly button marks the exact spot where your umbilical cord was once attached—the vital connection that provided oxygen and nutrients in the womb. Once you started breathing, eating, and discharging waste on your own, this cord was no longer needed. What remains is a mark, a reminder of your months in your mother’s womb. However, it often gets ignored as you grow up. And there is nothing wrong with that. Your belly button does not require a special skincare routine, but neglecting its hygiene can lead to a buildup of bacteria, potentially causing a smelly discharge.
But generally, a discharge from your belly button is normal and colourless. According to experts, normal discharge is typically clear or light-coloured, has a slight odor (similar to sweat), and has no pain or redness around the navel.
Experts say that the most common funk you might encounter in your belly button is a bacterial or fungal infection. A study titled
A Jungle in There: Bacteria in Belly Buttons are Highly Diverse, but Predictable published in 2012 in PLOS One Journal states that once rarefied to four hundred reads per sample, bacterial communities from belly buttons proved to be at least as diverse as communities known from other skin studies (on average 67 bacterial phylotypes per belly button).
This occurs due to poor hygiene, excessive sweating, or trapped moisture. Other conditions include navel piercings, cysts, and skin conditions like eczema or psoriasis. People with diabetes are particularly susceptible to fungal infections such as candidiasis if their blood sugar isn't under control, according to a 2019 review in the Journal of Clinical Medicine.
Bacteria and fungi love the dark environment of your belly button. If your belly button is infected, you might notice some redness or swelling. The discharge might look like pus, making your belly button smell bad. If it's a yeast infection, your belly button might also itch.
Belly button or naval piercing, if infected, can lead to severe pain, discolouration, swelling, discharge and pus. It can also cause the skin to appear red, causing delayed or failed healing.
Other common signs include:
Chills or fever
Persistent pain or inflammation
Sensitivity or discomfort when moving
Swelling or tenderness to touch
Credit: AI generated image
When women are in their 40s, their bodies start to change a lot because of the hormones. This is mainly because the estrogen and progesterone levels in the body start to go down. This time is called Perimenopause.
It is when women start to move towards menopause. It can bring a lot of emotional changes. Some of these changes are normal.
After 40, women's bodies start to produce estrogen. This means they can have an imbalance.
Women's bodies need hormones like estrogen and progesterone to have periods, strong bones, a good mood, and to stay at a healthy weight. When these hormone levels change, it affects parts of the body. This change can take a year before it stops at menopause.
Common hormonal changes women experience
While some changes are normal, some symptoms need a doctor's help:
When women are over 40 and their hormones change, they are more likely to have:
Estrogen helps keep the heart and bones healthy, so when its levels go down, women are more likely to have these health problems."
Women should talk about these changes openly. If they know what is happening and see a doctor early, they can make this time easier.
Hormonal changes after 40 are a part of getting older, but women should not ignore them. Especially if the symptoms are very bad or happen all the time.
If women understand what is happening in their bodies and see a doctor when they need to, they can be healthier and more confident. If women take care of themselves now, they can have a life in the years to come.
Credit: Canva/Tradeindia.com
The US Food and Drug Administration (FDA) has approved tradipitant to be sold under the brand name Nereus, for the prevention of vomiting induced by motion in adults — a first in the last four decades.
Motion sickness affects an estimated 65 to 78 million Americans—roughly 25 to 30 percent of adults—during everyday travel by car, plane, or boat. For decades, patients have had no meaningful new treatment options.
Tradipitant is an oral neurokinin-1 (NK-1) receptor antagonist that prevents motion-induced vomiting in adults.
It is an oral capsule, often taken 60 minutes before travel to block signals causing nausea.
The drug by Vanda Pharmaceuticals is now commercially available across the US.
"Today marks an important milestone for the tens of millions of Americans who experience motion sickness symptoms during common travel," said Mihael H. Polymeropoulos, M.D, President, CEO, and Chairman of Vanda, in a statement.
Motion sickness occurs when the brain receives conflicting signals from the eyes, inner ear, and body while in motion. This sensory mismatch is believed to trigger the release of substance P, which activates NK-1 receptors in the central nervous system and ultimately leads to nausea and vomiting.
Tradipitant works by blocking these receptors, interrupting the vomiting pathway.
"NEREUS is a selective, high-affinity antagonist of human substance P/neurokinin-1 (NK-1) receptors that can block the vomiting center of the brain,” Polymeropoulos said.
Tradipitant was approved by the FDA, following two pivotal Phase 3 clinical trials—Motion Syros and Motion Serifos—conducted under real-world conditions on the open sea.
Also read: India Installs US FDA-approved Portable MRI For Bedside Brain Scans At AIIMS Delhi
Both studies demonstrated that tradipitant significantly prevents vomiting compared to placebo, confirming the drug's effectiveness in actual sea travel conditions. It is the first new prescription option for people with a history of motion sickness in over 40 years.
It employs a novel mechanism as a selective, high-affinity antagonist of human substance P/NK-1 receptors. It offers simple dosing with just one or two capsules a day taken approximately an hour before travel.
Read More: CDC Warns Over Potential Surge In Measles Cases: Will The US Lose Its Elimination Status?
According to Vanda Pharmaceuticals, tradipitant may impair abilities required for driving a motor vehicle or operating heavy machinery.
Combining tradipitant with sedatives or medications that increase the drug's levels may increase this effect. If use together cannot be avoided, your doctor may warn against driving or operating heavy machinery.
The most common side effects associated with tradipitant include drowsiness, headache, and fatigue.
Moreover, strong CYP3A4 inhibitors may increase NEREUS™ levels and the risk of side effects, the company said.
There are limited data on tradipitant's use in pregnant women and children.
Tradipitant is also not recommended in patients with liver problems or severe kidney problems.
Credit: AI generated image
Type 2 diabetes was once rare among the young. Now, it is a common diagnosis for Indians in their 20s and 30s. The country currently faces a massive health crisis with 101 million confirmed diabetic patients and 136 million prediabetics. This sudden spike did not happen because human genetics broke down overnight. It happened because the way we live has completely transformed.
Asians (Indians ) already have a " thin- fat " body phenotype, which has a heavy genetic disadvantage. Even when an Indian person appears thin, they typically carry a much higher body fat percentage than a European person of the exact same weight. This fat builds up dangerously as visceral fat around the internal organs. Because of this, Indians develop severe insulin resistance at a much lower Body Mass Index (BMI).
Secondly, we tend to have faster beta-cell exhaustion. The pancreas simply stops producing enough insulin earlier in life.
Thirdly, if you have a positive family history, then the risk is higher and happens at an early age as compared to the previous generation.
But definitely it is not just genetics. Our DNA remains exactly the same as it was a century ago. Still, the age of onset is dropping at an alarming rate. Data from the massive ICMR-INDIAB study reveals that the real "take-off" point for diabetes now sits squarely in the 25 to 34 age bracket. Out of all the people under 25 diagnosed with diabetes today, one in four has Type 2. It used to be very rare to see anything other than Type 1 in young adults.
Now, the situation is completely different. States like Goa, Kerala, and Tamil Nadu are recording huge numbers, especially in city areas. Data collected in Tamil Nadu from 2006 to 2016 proved that the 20 to 39-year-old age group was getting sick at a faster pace than older generations. Across India, the total prevalence rate jumped from 7.1 percent to 11.4 percent. If current trends hold, we are looking at 152 million cases nationwide by 2045.
The absolute driver behind this youth explosion is a drastic shift in how we live. Urbanization wiped out physical activity. Young professionals sit at desks for ten hours, endure stressful commutes, and spend their remaining free time staring at screens.
Our diets worsened at the same time. Traditional balanced meals gave way to heavily refined carbohydrates and ultra-processed food, which the younger generation highly depends on. Polished white rice, refined wheat, and cheap ultra-processed foods flood our daily plates. Young people eat far less protein and fiber. This combination of daily sugar spikes and zero physical movement directly causes the abdominal obesity driving this epidemic.
The rapid rise in youth diabetes comes down to a severe gene-environment mismatch. Young Indians live in bodies biologically programmed to store fat to survive famines, but they now live in an environment of constant fast food and zero movement. We cannot rewrite our DNA. We can, however, change our daily habits.
As per RSSDI, early medical screening before age 25 is now an absolute necessity. Replacing heavy carbs with a low-carb, high-protein diet, fixing bad sleep schedules, and making time for daily physical activity can stop this crisis. Youth diabetes is entirely preventable. We just need to act before it is too late.
© 2024 Bennett, Coleman & Company Limited